RE:RE:RE:Summary of one-on-one discussion with ReliqOnce again, if anyone hasn't read azzy_m's posting on CEO.ca, I highly recommend doing so. I've never seen a posting on that bulletin board get so many thumbs up. Although there's a lot in the posting, here are a few key take aways for me:
1. Now we know precisely when patients are uploaded and that they have been checked for eligibility and have provided their consent FIRST. That makes info regarding the number of patients on the platform, revenue run rate and guidance more reliable.
2. Confirming that the device sales line item includes SaaS revenue is a big deal given that reported device revenue was much bigger than reported SaaS revenue in H1.
3. Confirmation that receivables collection is normalizing was expected and has now been acknowledged.
4. We now know that the large hardware deal was delayed due to a corporate take over, but is still possible. Good to have that explanation.
5. Their explanation that Cognizant's care management group are currently involved to get themselves trained up is good to know.
6. Nice to see a couple of RFPs with Cognizant in the works.